Share
CBS News
A long-awaited coronavirus vaccine could be available in roughly two months, according to drugmaker AstraZeneca, which is developing a treatment.
The Anglo-Swedish drugmaker is working with the University of Oxford to develop one of the most closely watched COVID-19 vaccines, which is in late stage trials in the U.S., the U.K. and other countries to determine its safety and effectiveness. Once those results are reported, regulators will have to approve the vaccine for widespread use.
AstraZeneca said it will analyze data from its vaccine trials in November and December. If the results look promising, it will move quickly to ramp up manufacturing and obtain government approval in the U.S. and elsewhere, Chief Executive Pascal Soriot said Thursday.
RELATED TOPICS:
Categories
Bakersfield to Host Sanders and AOC in ‘Fighting Oligarchy’ Event
Jaguar and Land Rover Maker Pauses Shipments to US as It Develops Post-Tariff Plans
China Hit Brakes on TikTok Deal After Trump Announced Wide-Ranging Tariffs
Shohei Ohtani Throws Second Bullpen Since Resuming Mound Ramp Up
Visalia Traffic Stop Nets $30K in Xanax, Marijuana
